Clinical observation of capecitabine continuous maintenance in treatment recurrence of triple-negative breast cancer with reaction to combined chemoradiotherapy
10.3969/j.issn.1671-8348.2015.24.016
- VernacularTitle:卡培他滨维持治疗对联合化疗有效的复发转移三阴乳腺癌的临床观察?
- Author:
Haitao LUO
;
Jinghe ZOU
;
Weiguang GU
;
Jianxin HU
;
Zhiren HE
;
Min XU
;
Shuxin LV
- Publication Type:Journal Article
- Keywords:
breast neoplasms;
infusions,intravenous;
neoplasm recurrence,local;
capecitabine;
continuous maintenance
- From:
Chongqing Medicine
2015;(24):3357-3359
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the clinical efficacy and safety of capecitabine continuous maintenance in treatment of re-currence of triple-negative breast cancer,which had responded to combined chemoradiotherapy.Methods The triple-negative breast cancer was defined as negative of ER,PR and HER2.A total of 46 patients of triple-negative breast cancer were divided into the treatment group (23 patients)and the control group (23 patients).The treatment group was given capecitabine continuous mainte-nance after 6 cycles of chemotherapy.The control group was given 6 cycles of combined chemotherapy only.The clinical efficacy and safety was evaluated between the two groups.Results The PR,PD,RR,and DCR in the treatment group were significantly higher than those in the control group(P <0.05).The acute toxic effects (except for hand-foot syndrome)were similar in two group(P >0.05).Conclusion Capecitabine continuous maintenance after combined chemoradiotherapy in treatment of recurrence of triple-neg-ative breast cancer is more effective,lower toxicity and tolerable.
